These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 16312168

  • 1. Effect of fluticasone propionate-salmeterol therapy on seasonal changes in airway responsiveness and exhaled nitric oxide levels in patients with pollen-induced asthma.
    Prieto L, Gutiérrez V, Pérez-Francés C, Badiola C, Lanuza A, Bruno L, Ferrer A.
    Ann Allergy Asthma Immunol; 2005 Nov; 95(5):452-61. PubMed ID: 16312168
    [Abstract] [Full Text] [Related]

  • 2. Effect of salmeterol/fluticasone propionate combination on airway hyper-responsiveness in patients with well-controlled asthma.
    Chanez P, Stallaert R, Reznikova E, Bloemen P, Adamek L, Joos G.
    Respir Med; 2010 Aug; 104(8):1101-9. PubMed ID: 20452196
    [Abstract] [Full Text] [Related]

  • 3. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 4. Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma.
    Fardon TC, Lee DK, Hodge MR, Lipworth BJ.
    Ann Allergy Asthma Immunol; 2005 Sep; 95(3):259-65. PubMed ID: 16200817
    [Abstract] [Full Text] [Related]

  • 5. Effects of low-dose fluticasone propionate/salmeterol combination therapy on exhaled nitric oxide and nitrite/nitrate in breath condensates from patients with mild persistent asthma.
    Pasha MA, Smith TC, Feustel PJ, Jourd'heuil D.
    J Asthma; 2013 Feb; 50(1):64-70. PubMed ID: 23098359
    [Abstract] [Full Text] [Related]

  • 6. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [Abstract] [Full Text] [Related]

  • 7. Fluticasone and ibuprofen do not add to the effect of salmeterol on organic dust-induced airway inflammation and bronchial hyper-responsiveness.
    Strandberg K, Ek A, Palmberg L, Larsson K.
    J Intern Med; 2008 Jul; 264(1):83-94. PubMed ID: 18298484
    [Abstract] [Full Text] [Related]

  • 8. Effect of salmeterol on seasonal changes in airway responsiveness and exhaled nitric oxide in pollen-sensitive asthmatic subjects.
    Prieto L, Gutiérrez V, Torres V, Uixera S, Marín J.
    Chest; 2002 Sep; 122(3):798-805. PubMed ID: 12226016
    [Abstract] [Full Text] [Related]

  • 9. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma.
    Fardon T, Haggart K, Lee DK, Lipworth BJ.
    Respir Med; 2007 Jun; 101(6):1218-28. PubMed ID: 17178217
    [Abstract] [Full Text] [Related]

  • 10. Central and peripheral airway/alveolar sites of exhaled nitric oxide in acute asthma.
    Gelb AF, George SC, Silkoff PE, Krishnan A, Fraser C, Taylor CF, Shinar CM, Maginot T.
    Thorax; 2010 Jul; 65(7):619-25. PubMed ID: 20627920
    [Abstract] [Full Text] [Related]

  • 11. The effect of airway remodelling on airway hyper-responsiveness in asthma.
    Kermode JA, Brown NJ, Hardaker KM, Farah CS, Berend N, King GG, Salome CM.
    Respir Med; 2011 Dec; 105(12):1798-804. PubMed ID: 21820298
    [Abstract] [Full Text] [Related]

  • 12. Effects of salmeterol and fluticasone propionate combination versus fluticasone propionate on airway function and eosinophilic inflammation in mild asthma.
    Hoshino M, Handa H, Miyazawa T.
    Allergol Int; 2009 Sep; 58(3):357-63. PubMed ID: 19454840
    [Abstract] [Full Text] [Related]

  • 13. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 14. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
    Dahl R, Chuchalin A, Gor D, Yoxall S, Sharma R.
    Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
    [Abstract] [Full Text] [Related]

  • 15. Reversal of the late asthmatic response increases exhaled nitric oxide.
    Boot JD, Tarasevych S, Sterk PJ, Schoemaker RC, Wang L, Amin D, Cohen AF, Diamant Z.
    Respir Med; 2005 Dec; 99(12):1591-4. PubMed ID: 15878654
    [No Abstract] [Full Text] [Related]

  • 16. Benefit from anti-inflammatory treatment during clinical remission of atopic asthma.
    van den Toorn LM, Prins JB, de Jongste JC, Leman K, Mulder PG, Hoogsteden HC, Overbeek SE.
    Respir Med; 2005 Jun; 99(6):779-87. PubMed ID: 15878496
    [Abstract] [Full Text] [Related]

  • 17. Salmeterol/fluticasone propionate combination product in asthma. An evaluation of its cost effectiveness vs fluticasone propionate.
    Pharmacoeconomics; 1999 Jun; 16 Suppl 2():i-viii, 1-34. PubMed ID: 10724799
    [No Abstract] [Full Text] [Related]

  • 18. A retrospective study of the use of fluticasone propionate/salmeterol combination as initial asthma controller therapy in a commercially insured population.
    Friedman H, Wilcox T, Reardon G, Crespi S, Yawn BP.
    Clin Ther; 2008 Oct; 30(10):1908-17. PubMed ID: 19014847
    [Abstract] [Full Text] [Related]

  • 19. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
    Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
    [Abstract] [Full Text] [Related]

  • 20. Initiation of maintenance treatment with salmeterol/fluticasone propionate 50/100 microg bd versus fluticasone propionate 100 microg bd alone in patients with persistent asthma: integrated analysis of four randomised trials.
    Barnes NC, Jacques L, Goldfrad C, Bateman ED.
    Respir Med; 2007 Nov 29; 101(11):2358-65. PubMed ID: 17689947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.